
Sirolimus by LC-MS/MS








The Sirolimus by LC-MS/MS is a blood test used to monitor the levels of sirolimus, an immunosuppressive medication commonly prescribed to prevent organ rejection in transplant recipients. It helps doctors ensure that individuals maintain optimal levels of sirolimus in their blood, reducing the risk of transplant rejection while avoiding toxicity. This test is used to optimize the dose so that toxic effects of the drug are avoided. The optimum time for the test is an hour before the next dose (trough).













Understanding Sirolimus by LC-MS/MS
Sirolimus is a powerful immunosuppressive medicine that works by inhibiting the immune system’s response to foreign organs, thereby preventing rejection after transplantation. Maintaining optimal levels of sirolimus is crucial, as insufficient levels may lead to organ rejection, while excessive levels can result in adverse effects and toxicity.
The Sirolimus by LC-MS/MS test is particularly useful for individuals who have undergone an organ transplant. This test helps physicians monitor medication adherence and provides valuable information to adjust dosages accordingly. It is typically performed at regular intervals post-transplant to ensure that individuals achieve and maintain the right levels of sirolimus in the body. The frequency of testing depends on factors such as individual response, type of transplant, time since transplant, age, and overall health. It is also performed when there are dosage changes or if symptoms of side effects, toxicity, or organ rejection are observed.
This test utilizes advanced LC-MS/MS (liquid chromatography-mass spectrometry) technology, allowing for the detection and precise quantification of even very low concentrations of sirolimus in the blood. LC-MS/MS offers higher sensitivity and specificity compared to immunoassays and is considered the gold standard. This enhances the reliability of results and enables timely, accurate dosage adjustments, helping physicians optimize treatment and reduce the risk of complications.
Before the Sirolimus by LC-MS/MS test, a brief medical history is needed, including the timing of transplantation, drug dosage, and the time of the last sirolimus dose. The test measures the ‘trough’ level (the lowest concentration) of sirolimus, typically just before the next scheduled dose, for consistent and accurate results. Therefore, it is advised to provide the blood sample just before the next dose (usually 12 hours post-dose), unless otherwise instructed by a physician. The patient should skip taking the morning dose on the day of testing. It is also advised to avoid grapefruit or grapefruit juice for 24 hours beforehand to ensure an accurate result. The timing of blood collection can significantly impact the measured levels of sirolimus. Meal timing, changes in administration route, or switching between brands of the medicine can also influence blood levels. Following a doctor’s instructions carefully ensures accurate testing and optimal treatment outcomes.
Lab test results may vary across methodologies and laboratories. Therefore, consistent monitoring using the same method and laboratory is recommended. Results may also vary based on age, medical history, or other risk factors. Abnormal results require expert interpretation. Never self-adjust medication at home based solely on test results. Maintaining optimal sirolimus levels improves overall health outcomes and supports long-term success in organ transplantation.
What does Sirolimus by LC-MS/MS measure?
The Sirolimus by LC-MS/MS test measures the levels of sirolimus in the blood. This test helps determine whether the concentration of sirolimus falls within the therapeutic range. Using LC-MS/MS technology, it can accurately detect very small amounts of sirolimus in the blood, providing precise information about the medication level.
Low levels indicate that the dosage may not be sufficient for effective immunosuppression or may reflect missed doses. High levels indicate potential toxicity and increased risk of adverse effects or organ damage. Accurate measurement ensures that doctors can safely adjust the dose, maintaining the right balance between effectiveness and safety, which is particularly critical for transplant patients requiring tight drug level monitoring.





FAQs related to Sirolimus by LC-MS/MS
- Treder N, Plenis A, Maliszewska O, Kaczmarczyk N, Olędzka I, Kowalski P, Bączek T, Bień E, Krawczyk MA, Roszkowska A. Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies. Open Med (Wars). 2023 Mar 2;18(1):20230652.
- Bouzas L, Hermida J, Tutor JC. Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method. Ups J Med Sci. 2009;114(1):55-61.
Other tests
- Comprehensive Check-up
- CRP (C-Reactive Protein), Quantitative
- Vitamin B12
- Magnesium
- TW-EYGDS HC
- Good Health Platinum Package with Smart Report
- Senior Citizen Health Checkup with Smart Report
- Men Health Checkup Premium with Smart Report
- Men Health Checkup Advanced with Smart Report
- Super Employee Health Check-up
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)














